Intralipid (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Intralipid drug offered from Baxter Healthcare Corporation. This Lipid Emulsion [EPC],Lipids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | SOYBEAN OIL |
SUBSTANCE NAME: | SOYBEAN OIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lipid Emulsion [EPC],Lipids [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | EMULSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-04-01 |
END MARKETING DATE: | 0000-00-00 |
Intralipid HUMAN PRESCRIPTION DRUG Details:
Item Description | Intralipid from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(g/100mL) |
START MARKETING DATE: | 2004-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-0519_a32b806c-59e2-4c5a-bd65-305edc8ec7d0 |
PRODUCT NDC: | 0338-0519 |
APPLICATION NUMBER: | NDA020248 |
Other SOYBEAN OIL Pharmaceutical Manufacturers / Labelers: